surpass 1 tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT SURPASS-CVOT Published: Large Trial Confirms

Both of these studies have similar results, making both medications effective for weight loss

You will barely see the liquid in the barrel

Manufacturer's Disclaimer If you are pregnant, nursing or taking any medications (such as nitrates), consult your doctor before use

Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits JACKSONVILLE, Fla., April 14, 2025 /PRNewswire/ -- In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss

Both formulations activate GLP-1 and GLP-1R/GIPR dual pathways, driving satiety, reduced appetite, and improved glycemic control